A Randomized, Placebo-Controlled Trial of Oral Silymarin (Milk Thistle) For Chronic Hepatitis C: Final Results of the SYNCH Multicenter Study. | | | Journal | 2011 | 10.1002/hep.24666 | SyNCH | | Contributing Study |
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. | 22797645 | PMC3683986 | Journal | 2012 | 10.1001/jama.2012.8265 | SyNCH | | Contributing Study |
Impact of Oral Silymarin Supplementation on Virus-Specific and Non-Virus-Specific T-Cells in Chronic Hepatitis C-Infected Patients. | | | Journal | 2012 | | SyNCH | | Contributing Study |
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C. | 22058086 | PMC3293174 | Journal | 2012 | 10.1177/1740774511427064 | SyNCH | | Contributing Study |